Inhibitory effects of flavonoids isolated from Sophora flavescens on indoleamine 2,3-dioxygenase 1 activity

Inhibitory effects of flavonoids isolated from Sophora flavescens on indoleamine 2,3-dioxygenase 1 activity

Indoleamine 2,3-dioxygenase 1 (IDO1), a tryptophan catabolising enzyme, is known as a tumour cell survival factor that causes immune escape in several types of cancer. Flavonoids of Sophora flavescens have a variety of biological benefits for humans; however, cancer immunotherapy effect has not been...

Full description

Bibliographic Details
Main Authors:	Mincheol Kwon, Sung-Kyun Ko, Mina Jang, Gun-Hee Kim, In-Ja Ryoo, Sangkeun Son, Hyung Won Ryu, Sei-Ryang Oh, Won-Kyu Lee, Bo Yeon Kim, Jae-Hyuk Jang, Jong Seog Ahn
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2019-01-01
Series:	Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:	indoleamine 2,3-dioxygenase 1 (ido1) ido1 inhibitor sophora flavescens flavonoid
Online Access:	http://dx.doi.org/10.1080/14756366.2019.1640218

Similar Items

The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2)
by: Chiara Suvieri, et al.
Published: (2024-11-01)

Indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources
by: Ying Tan, et al.
Published: (2022-11-01)

Significance of Indoleamine 2,3-Dioxygenase Expression in the Immunological Response of Kidney Graft Recipients
by: Krzysztof Wiśnicki, et al.
Published: (2022-09-01)

Immunohistochemical Detection of Indoleamine 2,3-Dioxygenase in Spontaneous Mammary Carcinomas of 96 Pet Rabbits
by: Sandra Schöniger, et al.
Published: (2024-07-01)

The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1
by: Eleonora Panfili, et al.
Published: (2023-04-01)

Role of indoleamine 2, 3-dioxygenase 1 in immunosuppression of breast cancer
by: Pratyasha Sarangi
Published: (2024-10-01)

Tryptophan deficiency induced by indoleamine 2,3‐dioxygenase 1 results in glucose transporter 1‐dependent promotion of aerobic glycolysis in pancreatic cancer
by: Heng Liang, et al.
Published: (2024-05-01)

IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression
by: Hanako Ohmatsu, et al.
Published: (2017-02-01)

Indoleamine 2,3-Dioxygenase (IDO) Activity: A Perspective Biomarker for Laboratory Determination in Tumor Immunotherapy
by: Pengbo Yang, et al.
Published: (2023-07-01)

Nanodelivery Optimization of IDO1 Inhibitors in Tumor Immunotherapy: Challenges and Strategies
by: Jiang K, et al.
Published: (2024-08-01)

Indoleamine 2,3-Dioxygenase Immune Status as a Potential Biomarker of Radioiodine Efficacy for Advanced Distant Metastatic Differentiated Thyroid Cancer
by: Liang Shi, et al.
Published: (2022-07-01)

Immunohistochemical Features of Indoleamine 2,3-Dioxygenase (IDO) in Various Types of Lymphoma: A Single Center Experience
by: Mee-seon Kim, et al.
Published: (2020-05-01)

Single Nucleotide Polymorphisms of Indoleamine 2,3-Dioxygenase 1 Influenced the Age Onset of Parkinson's Disease
by: Nóra Török, et al.
Published: (2022-09-01)

Hepatocellular Carcinoma Cells Are Protected From Immunolysis by Mesenchymal Stromal Cells Through Indoleamine 2,3 Dioxygenase
by: Raghavan Chinnadurai, et al.
Published: (2021-11-01)

Evaluation of mode of indoleamine 2,3-dioxygenase 1 inhibition by 4,7-dichloroquinolines
by: Niku Moni Das, et al.
Published: (2023-12-01)

IDO/kynurenine pathway in cancer: possible therapeutic approaches
by: Eslam E. Abd El-Fattah
Published: (2022-08-01)

Discovery of Novel Inhibitors of Indoleamine 2,3-Dioxygenase 1 Through Structure-Based Virtual Screening
by: Guoqing Zhang, et al.
Published: (2018-03-01)

On the nonredundant roles of TDO2 and IDO1
by: Paolo ePuccetti
Published: (2014-10-01)

Kushenol A and 8-prenylkaempferol, tyrosinase inhibitors, derived from Sophora flavescens
by: Jang Hoon Kim, et al.
Published: (2018-01-01)

The Prognostic Value of Indoleamine-2,3-Dioxygenase Gene Expression in Urine of Prostate Cancer Patients Undergoing Radical Prostatectomy as First Treatment of Choice
by: Michael Thüring, et al.
Published: (2020-08-01)

Characterization of the complete chloroplast genome of shrubby sophora (Sophora flavescens Ait.)
by: Wenlong Zhang, et al.
Published: (2018-07-01)

Characterization of the complete mitochondrial genome of shrubby sophora (Sophora flavescens Ait.)
by: Wenlong Zhang, et al.
Published: (2019-01-01)

The Coevolution of IDO1 and AhR in the Emergence of Regulatory T Cells in Mammals
by: Ursula eGrohmann, et al.
Published: (2015-02-01)

Maackiain, a compound derived from Sophora flavescens, increases IL‐1β production by amplifying nigericin‐mediated inflammasome activation
by: Jin‐Won Huh, et al.
Published: (2020-08-01)

Indoleamine 2,3-dioxygenase mediates the therapeutic effects of adipose-derived stromal/stem cells in experimental periodontitis by modulating macrophages through the kynurenine-AhR-NRF2 pathway
by: Hanyue Li, et al.
Published: (2022-12-01)

Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors
by: Chuan Zhou, et al.
Published: (2020-03-01)

1-MT inhibits the invasion of CBP-resistant ovarian cancer cells via down-regulating IDO expression and re-activating immune cells function
by: Huihan Ma, et al.
Published: (2020-09-01)

Prognostic role of indoleamine 2,3-dioxygenase 1 expression in solid tumors: A systematic review and meta-analysis
by: Haiyan Zhang, et al.
Published: (2022-09-01)

The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma
by: E Orecchini, et al.
Published: (2023-12-01)

Systemic tryptophan homeostasis
by: Simon Klaessens, et al.
Published: (2022-09-01)

Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors
by: Asha Nayak-Kapoor, et al.
Published: (2018-06-01)

PHYSICAL AND CHEMICAL METHODS FOR FLAVONOIDS CONTENT DETERMINATION IN SOPHORA FLAVESCENS ROOTS
by: A. B. Samoryadova
Published: (2015-09-01)

Ethnomedicinal uses, phytochemistry and bioactivities of Sophora flavescens Ait.: A review
by: ZHAO Jiaqi, et al.
Published: (2021-09-01)

Identification of Genetic Markers Linked to The Activity of Indoleamine 2,3-Dioxygenase and Kidney Function
by: Hye-Rim Kim, et al.
Published: (2023-04-01)

Beneficial or detrimental activity of regulatory T cells, indoleamine 2,3-dioxygenase, and heme oxygenase-1 in the lungs is influenced by the level of virulence of Mycobacterium tuberculosis strain infection
by: Vasti Lozano-Ordaz, et al.
Published: (2023-05-01)

Cloning, expression, and characterization of three ribosomal protein S13 genes in Sophora flavescens
by: Yi Liao, et al.
Published: (2018-10-01)

Research progress of indoleamine 2,3-dioxygenase 1 in gastric cancer
by: Pei Xiaxia, et al.
Published: (2023-03-01)

Increased Indoleamine 2,3-Dioxygenase 1 (IDO-1) Activity and Inflammatory Responses during Chikungunya Virus Infection
by: Thiara Manuele Alves de Souza, et al.
Published: (2022-04-01)

Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells
by: Sofia Rossini, et al.
Published: (2024-01-01)

Production of Flavonoids in Callus Cultures of <i>Sophora flavescens</i> Aiton
by: Ji-Sun Park, et al.
Published: (2020-05-01)